Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis
Stephanie N. Blandford, Dylan A. Galloway, John B. Williams, Shane Arsenault, Janet E. Brown, Gregg MacLean, G. R. Wayne Moore, Jane Barron, Michelle Ploughman, Fraser Clift, Mark Stefanelli, Craig S. Moore
Topics & Concepts
Multiple sclerosisMedicineBiomarkerInterleukin 1 receptor antagonistMicrogliaReceptor antagonistExpanded Disability Status ScaleImmunologyCerebrospinal fluidInterleukinPathologyInternal medicineReceptorAntagonistInflammationCytokineBiologyBiochemistryMultiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration MechanismsInflammasome and immune disorders